Gene therapy for the treatment of sensory neuropathy (Q36446943)

14 August 2017

1 reference

title

Gene therapy for the treatment of sensory neuropathy (English)

1 reference

14 August 2017

0 references

Marina Mata

1 reference

14 August 2017

Munmun Chattopadhyay

series ordinal

1 reference

14 August 2017

David J Fink

series ordinal

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

Expert Opinion on Biological Therapy

14 August 2017

published in

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

14 August 2017

page(s)

499-507

1 reference

Epidemiology of peripheral neuropathy

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

The role of neurotrophins in the developing nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Fibroblast growth factors in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Reversal of experimental diabetic neuropathy by VEGF gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Emerging biological roles for erythropoietin in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Insulin-like growth factor I increases myelination and inhibits demyelination in cultured organotypic nerve tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Regulation of rat Schwann cell Po expression and DNA synthesis by insulin-like growth factors in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Role of insulin-like growth factors in peripheral nerve regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Reversal by NGF of cytostatic drug-induced reduction of neurite outgrowth in rat dorsal root ganglia in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Nerve growth factor administration protects against experimental diabetic sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Role of vascular endothelial growth factor in neuronal DNA damage and repair in rat brain following a transient cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

In vivo evidence that erythropoietin protects neurons from ischemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Neurotrophic factor therapy--prospects and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Partial prevention of cisplatin-induced neuropathy by electroporation-mediated nonviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Viral and non-viral gene therapy partially prevents experimental cisplatin-induced neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Nonviral gene transfer of human hepatocyte growth factor improves streptozotocin-induced diabetic neuropathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Gene transfer to neurons using herpes simplex virus-based vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Herpes vector-mediated gene transfer in treatment of diseases of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

A complex formed between cell components and an HSV structural polypeptide binds to a viral immediate early gene regulatory DNA sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Host cell proteins bind to the cis-acting site required for virion-mediated induction of herpes simplex virus 1 alpha genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

The VP16 accessory protein HCF is a family of polypeptides processed from a large precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Latent herpes simplex virus type 1 DNA is not extensively methylated in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Physical state of the latent herpes simplex virus genome in a mouse model system: evidence suggesting an episomal state

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Design and application of HSV vectors for neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Engineering herpes simplex virus vectors for CNS applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

In vivo gene therapy for pyridoxine-induced neuropathy by herpes simplex virus-mediated gene transfer of neurotrophin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Nerve growth factor protects adult sensory neurons from cell death and atrophy caused by nerve injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Pharmacological effects of nerve growth factor and fibroblast growth factor applied to the transectioned sciatic nerve on neuron death in adult rat dorsal root ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Nerve growth factor facilitates regeneration across nerve gaps: morphological and behavioral studies in rat sciatic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Insulin-like growth factor I: a mitogen for rat Schwann cells in the presence of elevated levels of cyclic AMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Insulin and the insulin-like growth factors I and II are mitogenic to cultured rat sciatic nerve segments and stimulate [3H]thymidine incorporation through their respective receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

The insulin-like growth factors I and II stimulate proliferation of different types of Schwann cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Insulin-like growth factor-I (IGF-I) and IGF binding protein-5 in Schwann cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Nerve growth factor prevents neurotoxic effects of cisplatin, vincristine and taxol, on adult rat sympathetic ganglion explants in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

The effect of nerve growth factor, ciliary neurotrophic factor, and ACTH analogs on cisplatin neurotoxicity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Nerve growth factor prevents experimental cisplatin neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Neurotrophin‐3 reverses experimental cisplatin‐induced peripheral sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Insulin-like growth factors protect against diabetic neuropathy: effects on sensory nerve regeneration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Insulin-like growth factors reverse or arrest diabetic neuropathy: effects on hyperalgesia and impaired nerve regeneration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.5.499

21 January 2018

Identifiers

DOI

10.1517/14712598.6.5.499

1 reference

14 August 2017

1 reference